Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2005
03/10/2005WO2003072542A3 Interfacial biomaterials
03/10/2005WO2003065003A3 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
03/10/2005WO2003052062A3 Antisense modulation of cd36l1 expression
03/10/2005WO2003027254A9 15625 receptor, a novel g-protein coupled receptor
03/10/2005WO2003010290A3 Novel class ii cytokine receptors and uses thereof
03/10/2005WO2002094989A3 Retroviral vectors and methods of using same
03/10/2005WO2002077165A3 Glycoconjugate synthesis using a pathway-engineered organism
03/10/2005WO2001066772A9 Heparinase iii and uses thereof
03/10/2005WO2001011335A3 Antiviral compounds that inhibit viral replication
03/10/2005US20050055748 Expression vector comprising raffinose regulatory sequences for use as tool in generating drought, salinity, heat and cold resistant plants; enhancing crop yields
03/10/2005US20050055746 Enhancing leaf protein concentration in plant via transformmation with vector comprising nucleotide sequences which code for serine and aspartate protease inhibitors; tissue engineering and enhancing animal feeds
03/10/2005US20050055745 Leaf longevity protein (ORE-7) for use in controlling senescence in plants; enhancing crop yield, viability and growing season
03/10/2005US20050055744 Nuclelotide sequences coding elongase (ELONG) and an enzyme involved in glucosinolate side-chain desaturation (ALK) for use as tools in controlling bitterness of plants; flavor enhance in crops
03/10/2005US20050055742 Plant regulatory element
03/10/2005US20050055741 Transgenic plant comprising nucleotide sequences coding silencing element binding factor protein (SEBF) for use in identifying modulator which enhance/decrease plants resistance pathogens; disease resistant plants
03/10/2005US20050055740 Genetically engineered plants comprising minigene vectors for use as bioreactor for heterologous gene expression
03/10/2005US20050055738 Methods and compositions for regulation of cell death in plants
03/10/2005US20050055737 Engineered rna translocators
03/10/2005US20050055736 Multicomponent device comprising flat plate and oscillation means for separating canola seeds on the basis of ripeness
03/10/2005US20050055734 Prenatal screening
03/10/2005US20050055072 Light activated gene transduction for cell targeted gene delivery in the spinal column
03/10/2005US20050054969 Electromanipulation Device and Method
03/10/2005US20050054847 Compositions and methods for preparing short RNA molecules and other nucleic acids
03/10/2005US20050054845 Thymosin augmentation of genetic immunization
03/10/2005US20050054843 Subtilisin comprising b-cell epitope for use in detergents, textile treatment, liquid soaps, cosmetics and contact lense cleaning solutions
03/10/2005US20050054836 Chimeric molecules to modulate gene expression
03/10/2005US20050054835 Immunoglobulin fusion comprising gelonin and shiga-like toxin for use in treatment and prevention of graft vs host, autoimmue and cell proliferative disorders
03/10/2005US20050054833 Immunoglobulin fusion for use in treatment and prevention of asthma, food allergies, sinus inflammation and vision defects
03/10/2005US20050054831 Osmotic stress-inducible protein functioning as a negative regulator in osmotic stress signaling pathway of plants
03/10/2005US20050054828 Proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
03/10/2005US20050054827 Conotoxin amino acid sequences for use as tool in controlling pain; immunotherapy; mimetics
03/10/2005US20050054825 Osteogenic devices
03/10/2005US20050054823 Genes
03/10/2005US20050054822 High in normal-2 (HIN-1) protein for use in the identifying modulators for treatment of infection and respiratory system disorders
03/10/2005US20050054821 Fusion proteins for insect control
03/10/2005US20050054820 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy
03/10/2005US20050054617 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
03/10/2005US20050054604 Labile linkage for compound delivery to a cell
03/10/2005US20050054603 gene expression inhibition; hairpin nucleic acids; for treatment of viral infections, tumors, and cancer
03/10/2005US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders
03/10/2005US20050054601 Modified polynucleotides with phosphorothiolate linkage; animal growth regulators; immunomoderators; immunotherapy ; autoimmune disease
03/10/2005US20050054600 Modified protein kinase a-specific oligonucleotides and methods of their use
03/10/2005US20050054598 RNA interference mediated inhibition hairless (HR) gene expression using short interfering nucleic acid (siNA)
03/10/2005US20050054597 Controlling error frequencyof gene reproduction; using polymerase
03/10/2005US20050054596 useful in modulating vascular endothelial growth factor (VEGF) and/or vascular endothelial growth factor receptor (e.g., VEGFR) gene expression; used in therapeutic, diagnostic, target validation, and genomic discovery
03/10/2005US20050054594 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
03/10/2005US20050054593 New drug
03/10/2005US20050054592 Alzheimer's disease; Parkinson's disease; isolated nucleic acids
03/10/2005US20050054575 Peptide agonists of prostate-specific antigen and uses therefor
03/10/2005US20050054570 For prophylaxis and therapy of diabetes
03/10/2005US20050054564 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine
03/10/2005US20050054563 Transgenic bacteria host cell can be used for screening antibiotics , herbicides; genetic engineering; therapy for bone disorders; antiarthritic agents
03/10/2005US20050054529 Pesticide for transgenic crops
03/10/2005US20050054108 Yeast membrane protein expression system and its application in drug screening
03/10/2005US20050054107 Replicon particles comprising viral proteins for use in vaccines against viral disease; viricides
03/10/2005US20050054106 DNA recombination in eukaryotic cells by the bacteriophage PHIC31 recombination system
03/10/2005US20050054105 Expression vector comprising inverted terminal repeats for use as gene transfer tool in genetic engineering; genetic vaccines
03/10/2005US20050054104 Expression vector for use in transfer of heterologous nucleotide sequences into cells expressing FLT3 (FMS-like tyrosine kinase 3); drug delivery; genetic vaccines
03/10/2005US20050054103 Using enzyme inhibitor to prevent phosphatidylinositol 3-kinase (PI 3-kinase) activity and expand preferential cell populations; regenerative medicine; tissue engineering; immunotherapy
03/10/2005US20050054102 Culturing preferential stem cells and generating pancreatic beta cell tissues via transfection for use in treatment of diabetes, hyperglycemia, and/or impaired glucose tolerance; tissue engineering; regenerative medicine
03/10/2005US20050054090 MHC class II antigen-presenting systems and methods for activating CD4cells
03/10/2005US20050054076 Escherichia coli (E. coli) strain capable of producing L-threonine in high yield; expression repression of threonine biosynthesis genes by a metJ gene product is prevented, thereby producing a high concentration of threonine
03/10/2005US20050054075 Attenuated bacteria useful in vaccines
03/10/2005US20050054074 Cell line comprising embryonated poultry cells and attenuated viral particles for use as tool in generation of vaccine for treatment and prevention of in fection by of influenza virus; immunotherapeutics
03/10/2005US20050054073 Cytidine deaminase
03/10/2005US20050054067 Process for producing dipeptide,l-amino acid amide hydrolase to be used therein and process for producing l-amino acid amide hydrolase
03/10/2005US20050054066 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
03/10/2005US20050054065 High-activity phytase compositions
03/10/2005US20050054062 Gene conferring lysozyme insensitivity to Corynebacterium
03/10/2005US20050054061 Using transgenic gramnegative bacteria as bioreactor for fermentation of histidine to be used in medicine, cosmetics and animal feeds
03/10/2005US20050054060 Method for the preparation of an evolved microorganism for the creation or the modification of metabolic pathways
03/10/2005US20050054055 Using transgenic rodents as bioreactor for generation of immunoglobulins for use as tools in immunotherapeutics and diagnostics
03/10/2005US20050054052 Therapeutic cytokine for use in prevention and treatment of viral diseases
03/10/2005US20050054051 Albumin fusion proteins
03/10/2005US20050054050 Green fluorescent protein for use as diagnostic indicator of genic expression in transformed cells; genetic engineering
03/10/2005US20050054049 Novel human transporter proteins and polynucleotides encoding the same
03/10/2005US20050054048 Generating preferential immunoglobulins in hypermutable cells for use as tools in antibody-dependent cellular cytotoxicity; immunotherapy
03/10/2005US20050054046 Evaluating safety, efficacy and biological properties of immunoglobulin receptors; immunotherapeutic agents
03/10/2005US20050054045 Novel G-protein coupled receptor
03/10/2005US20050054042 Novel gluconate dehydratase
03/10/2005US20050054041 Kini-3 motor protein and methods for its use
03/10/2005US20050054040 Novel human semaphorin homologs and polynucleotides encoding the same
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050054034 Polypeptide encoding by a polynucleotide; for detecting diseases; use in diagnosis and in identifying compounds that may be agonists, antagonists as biodrug treating diseases; host cell culturing
03/10/2005US20050054032 Methods of decoupling reaction scale and protein synthesis yield in batch mode
03/10/2005US20050054019 Human monoclonal antibody for use in the diagnosis prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics
03/10/2005US20050054018 Using cell cycle checkpoint activation modulators to prevent and treat cell proliferative disorders
03/10/2005US20050054007 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof
03/10/2005US20050053997 Synthesizing polynucleotide sequences based on model generated sequences; bioinformatics; directed evolution of proteins
03/10/2005US20050053995 Staphylococcus aureus genes and polypeptides
03/10/2005US20050053994 Expression vector comprising nucleotide sequences coding phosphodiesterase for use in the treatment and prevention of autoimmune, respiratory system and pulmonary disorders; gene therapy; tissue engineering
03/10/2005US20050053990 Identifying RNA viral sequences using restriction enzymes specific for RNA/DNA duplexes; primer biosynthesis; pathogen detection
03/10/2005US20050053989 Libraries of recombinant chimeric proteins
03/10/2005US20050053979 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same
03/10/2005US20050053972 Method for identifying polymorphisms
03/10/2005US20050053970 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
03/10/2005US20050053964 Oligonucleotide identifiers
03/10/2005US20050053959 Orthohydroxyphenylpropionic acid inducible expression vector comprising chimeric gene sequences for use as tool in heterologous gene transfer into plants; tissue engineering and improving exogenous gene expression
03/10/2005US20050053953 Novel human genes and proteins encoded thereby
03/10/2005US20050053951 Riboswitches, methods for their use, and compositions for use with riboswitches
1 ... 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 ... 4023